.
.
.
.
Coronavirus

COVAX signs deal for 500 mln Moderna COVID-19 vaccine doses

Published: Updated:

The COVAX global vaccine equity program has signed an advance purchase agreement with Moderna for 500 million doses of its COVID-19 jabs, the scheme’s co-leaders Gavi announced Monday.

For more coronavirus news, visit our dedicated page.

“We are very pleased to sign this new agreement with Moderna, giving Covax facility participants access to yet another highly efficacious vaccine,” Seth Berkley, chief executive of the Gavi vaccine alliance, said in a statement.